{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:06:39Z","timestamp":1789038399208,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"am","delay-in-days":461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004007","name":"Italian National Institute of Nuclear Physics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004007","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jconrel.2018.04.043","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T16:51:39Z","timestamp":1525366299000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["An innovative therapeutic approach for malignant mesothelioma treatment based on the use of Gd\/boron multimodal probes for MRI guided BNCT"],"prefix":"10.1016","volume":"280","author":[{"given":"Diego","family":"Alberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Deagostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Toppino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Protti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silva","family":"Bortolussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Aime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2998-5424","authenticated-orcid":false,"given":"Simonetta","family":"Geninatti Crich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.04.043_bb0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: the standard of care and challenges for future management","volume":"78","author":"van Meerbeeck","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"10.1016\/j.jconrel.2018.04.043_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09059180.00007014","article-title":"Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic","volume":"24","author":"R\u00f8e","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0015","doi-asserted-by":"crossref","first-page":"53751","DOI":"10.18632\/oncotarget.17910","article-title":"Biomarkers for early diagnosis of malignant mesothelioma: do we need another moonshot?","volume":"8","author":"Lagniau","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2018.04.043_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/srep45768","article-title":"HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma","volume":"7","author":"Tsuji","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0025","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150207","article-title":"Applications of nanoparticles for diagnosis and therapy of cancer","volume":"88","author":"Baetke","year":"2015","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.copbio.2013.11.014","article-title":"Biological nanoparticles and their influence on organisms","volume":"28","author":"Stanley","year":"2014","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2016.05.006","article-title":"Comparison of two endogenous delivery agents in cancer therapy: Exosomes and ferritin","volume":"110","author":"Li","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2016.04.020","article-title":"Lipoproteins and lipoprotein mimetics for imaging and drug delivery","volume":"106 (","author":"Thaxton","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0045","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1593\/neo.07682","article-title":"Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles","volume":"9","author":"Geninatti Crich","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2018.04.043_bb0050","series-title":"Boron and Gadolinium Neutron Capture Therapy for Cancer Treatment","author":"Hosmane","year":"2012"},{"key":"10.1016\/j.jconrel.2018.04.043_bb0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4103\/0973-1482.176167","article-title":"Boron neutron capture therapy: moving toward targeted cancer therapy","volume":"12","author":"Mirzaei","year":"2016","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0060","first-page":"907","article-title":"Novel hyaluronan formulation enhances the efficacy of boron neutron capture therapy for murine mesothelioma","volume":"36","author":"Sasai","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0065","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.ijrobp.2006.08.026","article-title":"Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis","volume":"66","author":"Suzuki","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0070","series-title":"Neutron Capture Therapy, Principles and Applications","author":"Sauerwein","year":"2012"},{"key":"10.1016\/j.jconrel.2018.04.043_bb0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1748-717X-7-146","article-title":"Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer","volume":"7","author":"Barth","year":"2012","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0080","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.apradiso.2009.03.102","article-title":"Boron neutron capture therapy at the crossroads: challenges and opportunities","volume":"67","author":"Barth","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/187152012800617786","article-title":"Boronated compounds for imaging guided BNCT applications","volume":"12","author":"Geninatti-Crich","year":"2012","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-8545(02)00087-5","article-title":"The medicinal chemistry of carboranes","volume":"232","author":"Valliant","year":"2002","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/187152006776119153","article-title":"Boron containing macromolecules and Nanovehicles as delivery agents for neutron capture therapy","volume":"6","author":"Wu","year":"2006","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0100","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jorganchem.2008.10.059","article-title":"Syntheses of C-substituted icosahedral dicarboranes bearing the 8-dioxane-cobalt bisdicarbollide moiety","volume":"694","author":"\u0160\u00edcha","year":"2009","journal-title":"J. Organomet. Chem."},{"issue":"10","key":"10.1016\/j.jconrel.2018.04.043_bb0105","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1039\/C7DT00100B","article-title":"Carborane-layered double hydroxide nanohybrids for potential targeted- and magnetically targeted-BNCT applications","volume":"46","author":"Ay","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0110","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1002\/chem.201003741","article-title":"MRI-guided neutron capture therapy by use of a dual gadolinium\/boron agent targeted at tumor cells through upregulated low-density lipoprotein transporters","volume":"17","author":"Geninatti-Crich","year":"2011","journal-title":"Chemistry"},{"key":"10.1016\/j.jconrel.2018.04.043_bb0115","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.nano.2014.12.004","article-title":"A theranostic approach based on the use of a dual boron\/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment","volume":"11","author":"Alberti","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.04.043_bb0120","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1039\/b808804g","article-title":"Synthesis of Gd(III)-C-palmitamidomethyl-C'-DOTAMA-C(6)-o-carborane: a new dual agent for innovative MRI\/BNCT applications","volume":"6","author":"Aime","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0125","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1158\/0008-5472.CAN-04-3947","article-title":"Magnetic resonance imaging visualization of hyaluronidase in ovarian carcinoma","volume":"65","author":"Shiftan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0130","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.apradiso.2009.03.087","article-title":"Extra-corporeal liver BNCT for the treatment of diffusemetastases: what was learned and what is still to be learned","volume":"67","author":"Zonta","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nimb.2017.10.023","article-title":"Neutron flux and gamma dose measurement in the BNCT irradiation facility at the TRIGA reactor of the University of Pavia","volume":"414","author":"Bortolussi","year":"2018","journal-title":"NIM-B"},{"key":"10.1016\/j.jconrel.2018.04.043_bb0140","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/HP.0000000000000148","article-title":"Gamma residual radioactivity measurements on rats and mice irradiated in the thermal column of a TRIGA mark II reactor for BNCT","volume":"107","author":"Protti","year":"2014","journal-title":"Health Phys."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13691-012-0048-8","article-title":"Reirradiation for locally recurrent lung cancer in the chest wall with boron neutron capture therapy (BNCT)","volume":"1","author":"Suzuki","year":"2012","journal-title":"Int. Cancer Conf. J."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0150","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ejmp.2014.07.342","article-title":"Exploring Boron Neutron Capture Therapy for non-small cell lung cancer","volume":"30","author":"Farias","year":"2014","journal-title":"Phys. Med."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.apradiso.2004.05.021","article-title":"Effects of boron neutron capture irradiation on the normal lung of rats","volume":"61","author":"Kiger","year":"2004","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1667\/RR1266.1","article-title":"Functional and histological changes in rat lung after boron neutron capture therapy","volume":"179","author":"Kiger","year":"2008","journal-title":"Radiat. Res."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.apradiso.2015.07.060","article-title":"Boron neutron capture therapy as a new approach fro clear cell sarcoma treatment: trial using a lung metastasis model of CCS","volume":"106","author":"Andoh","year":"2015","journal-title":"Appl. Radiat. Isot."},{"issue":"4","key":"10.1016\/j.jconrel.2018.04.043_bb0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jjco\/hym022","article-title":"A preliminary experimental study of boron neutron capture therapy for malignant tumours spreading in thoracic cavity","volume":"37","author":"Suzuki","year":"2007","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2018.04.043_bb0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rpor.2014.11.004","article-title":"Present status of accelerator-based BNCT","volume":"21","author":"Kreiner","year":"2016","journal-title":"Rep. Pract. Oncol. Radiother."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591830227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591830227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:33:58Z","timestamp":1759160038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591830227X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":35,"alternative-id":["S016836591830227X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.04.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An innovative therapeutic approach for malignant mesothelioma treatment based on the use of Gd\/boron multimodal probes for MRI guided BNCT","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}